Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Correction: Survivin Mutant Protects Differentiated Dopaminergic SK-N-SH Cells Against Oxidative Stress.

Baratchi S, Kanwar RK, Kanwar JR.

PLoS One. 2018 Mar 15;13(3):e0194587. doi: 10.1371/journal.pone.0194587. eCollection 2018.

2.

Erratum: "Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells" [Biomicrofluidics 9(5), 054110 (2015)].

Maremanda NG, Roy K, Kanwar RK, Shyamsundar V, Ramshankar V, Krishnamurthy A, Krishnakumar S, Kanwar JR.

Biomicrofluidics. 2017 Aug 21;11(4):049901. doi: 10.1063/1.4999489. eCollection 2017 Jul.

3.

Progress on Azadirachta indica Based Biopesticides in Replacing Synthetic Toxic Pesticides.

Chaudhary S, Kanwar RK, Sehgal A, Cahill DM, Barrow CJ, Sehgal R, Kanwar JR.

Front Plant Sci. 2017 May 8;8:610. doi: 10.3389/fpls.2017.00610. eCollection 2017. Review.

4.

Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze.

Roy K, Cheung CHA, Kanwar RK, Sandhir R, Kanwar JR.

Front Pharmacol. 2017 May 5;8:223. doi: 10.3389/fphar.2017.00223. eCollection 2017.

5.
6.

Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imaging.

Subramanian N, Srimany A, Kanwar JR, Kanwar RK, Akilandeswari B, Rishi P, Khetan V, Vasudevan M, Pradeep T, Krishnakumar S.

Mol Ther Nucleic Acids. 2016 Aug 30;5(8):e358. doi: 10.1038/mtna.2016.70.

7.

Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.

Roy K, Sriramoju B, Kanwar RK, Kanwar JR.

Front Pharmacol. 2016 Jul 28;7:226. doi: 10.3389/fphar.2016.00226. eCollection 2016. Retraction in: Front Pharmacol. 2017 Jun 21;8:426.

8.

Studies to Prevent Degradation of Recombinant Fc-Fusion Protein Expressed in Mammalian Cell Line and Protein Characterization.

Chakrabarti S, Barrow CJ, Kanwar RK, Ramana V, Kanwar JR.

Int J Mol Sci. 2016 Jun 9;17(6). pii: E913. doi: 10.3390/ijms17060913.

9.

Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers.

Kamalapuram SK, Kanwar RK, Roy K, Chaudhary R, Sehgal R, Kanwar JR.

Int J Nanomedicine. 2016 Apr 1;11:1349-66. doi: 10.2147/IJN.S95253. eCollection 2016.

10.

Neurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib.

Podratz JL, Kulkarni A, Pleticha J, Kanwar R, Beutler AS, Staff NP, Windebank AJ.

J Neurol Sci. 2016 Mar 15;362:131-5. doi: 10.1016/j.jns.2015.12.038. Epub 2015 Dec 28.

11.

Targeted alignment and end repair elimination increase alignment and methylation measure accuracy for reduced representation bisulfite sequencing data.

Baheti S, Kanwar R, Goelzenleuchter M, Kocher JP, Beutler AS, Sun Z.

BMC Genomics. 2016 Feb 27;17:149. doi: 10.1186/s12864-016-2494-8.

12.

Trimester specific reference intervals for thyroid function tests in normal Indian pregnant women.

Sekhri T, Juhi JA, Wilfred R, Kanwar RS, Sethi J, Bhadra K, Nair S, Singh S.

Indian J Endocrinol Metab. 2016 Jan-Feb;20(1):101-7. doi: 10.4103/2230-8210.172239.

13.

Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.

Chaudhary R, Roy K, Kanwar RK, Walder K, Kanwar JR.

J Nanobiotechnology. 2016 Jan 16;14:6. doi: 10.1186/s12951-016-0157-1.

14.

Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance).

Boora GK, Kanwar R, Kulkarni AA, Abyzov A, Sloan J, Ruddy KJ, Banck MS, Loprinzi CL, Beutler AS.

Cancer Med. 2016 Apr;5(4):631-9. doi: 10.1002/cam4.625. Epub 2016 Jan 14.

15.

Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.

Roy K, Patel YS, Kanwar RK, Rajkhowa R, Wang X, Kanwar JR.

Int J Nanomedicine. 2015 Dec 21;11:25-44. doi: 10.2147/IJN.S91810. eCollection 2016.

16.

Neurobehavioral burden of multiple sclerosis with nanotheranostics.

Sriramoju B, Kanwar RK, Kanwar JR.

Neuropsychiatr Dis Treat. 2015 Oct 15;11:2675-89. doi: 10.2147/NDT.S82768. eCollection 2015. Review.

17.

Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii.

Anand N, Sehgal R, Kanwar RK, Dubey ML, Vasishta RK, Kanwar JR.

Int J Nanomedicine. 2015 Oct 8;10:6355-69. doi: 10.2147/IJN.S85286. eCollection 2015.

18.

Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells.

Maremanda NG, Roy K, Kanwar RK, Shyamsundar V, Ramshankar V, Krishnamurthy A, Krishnakumar S, Kanwar JR.

Biomicrofluidics. 2015 Sep 29;9(5):054110. doi: 10.1063/1.4930983. eCollection 2015 Sep. Erratum in: Biomicrofluidics. 2017 Aug 21;11(4):049901.

19.

Molecular targets in arthritis and recent trends in nanotherapy.

Roy K, Kanwar RK, Kanwar JR.

Int J Nanomedicine. 2015 Aug 26;10:5407-20. doi: 10.2147/IJN.S89156. eCollection 2015. Review.

20.

Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite-host interaction.

Anand N, Kanwar RK, Dubey ML, Vahishta RK, Sehgal R, Verma AK, Kanwar JR.

Drug Des Devel Ther. 2015 Jul 27;9:3821-35. doi: 10.2147/DDDT.S77860. eCollection 2015.

Supplemental Content

Loading ...
Support Center